Lifevantage Shares Outstanding 2010-2024 | LFVN

Lifevantage shares outstanding from 2010 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Lifevantage Annual Shares Outstanding
(Millions of Shares)
2024 13
2023 13
2022 13
2021 14
2020 15
2019 15
2018 14
2017 14
2016 15
2015 14
2014 16
2013 18
2012 17
2011 10
2010 8
2009 6
Lifevantage Quarterly Shares Outstanding
(Millions of Shares)
2024-09-30 13
2024-06-30 13
2024-03-31 13
2023-12-31 13
2023-09-30 13
2023-06-30 13
2023-03-31 13
2022-12-31 13
2022-09-30 12
2022-06-30 13
2022-03-31 13
2021-12-31 13
2021-09-30 13
2021-06-30 14
2021-03-31 14
2020-12-31 14
2020-09-30 15
2020-06-30 15
2020-03-31 15
2019-12-31 15
2019-09-30 15
2019-06-30 15
2019-03-31 15
2018-12-31 15
2018-09-30 15
2018-06-30 14
2018-03-31 14
2017-12-31 14
2017-09-30 14
2017-06-30 14
2017-03-31 14
2016-12-31 14
2016-09-30 14
2016-06-30 15
2016-03-31 14
2015-12-31 14
2015-09-30 14
2015-06-30 14
2015-03-31 14
2014-12-31 14
2014-09-30 15
2014-06-30 16
2014-03-31 15
2013-12-31 16
2013-09-30 18
2013-06-30 18
2013-03-31 18
2012-12-31 18
2012-09-30 18
2012-06-30 17
2012-03-31 15
2011-12-31 17
2011-09-30 17
2011-06-30 12
2011-03-31 10
2010-12-31 13
2010-09-30 13
2010-06-30 9
2010-03-31 8
2009-12-31 8
2009-09-30 8
2009-06-30 7
2009-03-31 4
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.170B $0.200B
Lifevantage Corporation is a health and nutrition company. The company is the maker of Protandim(R), the Nrf2 Synergizer(R) patented dietary supplement, the TrueScience(TM) Anti-Aging Skin Care Regimen, Canine Health and the AXIO(TM) energy product line. Lifevantage Corporation is headquartered in Salt Lake City, Utah.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $78.151B 21.33
Becton Dickinson (BDX) United States $64.352B 16.92
Cardinal Health (CAH) United States $28.637B 15.53
West Pharmaceutical Services (WST) United States $22.024B 44.99
Labcorp (LH) United States $19.758B 16.38
Cooper (COO) United States $19.726B 28.08
Align Technology (ALGN) United States $16.616B 31.80
Henry Schein (HSIC) United States $9.331B 17.78
Merit Medical Systems (MMSI) United States $6.102B 31.16
DENTSPLY SIRONA (XRAY) United States $3.753B 10.20
CONMED (CNMD) United States $2.216B 18.49
Patterson (PDCO) United States $1.799B 9.49
STAAR Surgical (STAA) United States $1.288B 47.53
Pro-Dex (PDEX) United States $0.147B 29.36